Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$298,953
-$47,947 QoQ
Shares Held
12,415
+0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#2,134
of 2,821 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026US Asset Management LLC holds $3,864,282 across 4 Drug Manufacturers - General names. PFE ranks #4 (7.7% of the industry book) .
All Filings in PFE
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $298,953 | 12,415 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $346,900 | 12,354 | Shares | Sole | 2026-06-10 | |
| 2025-12-31 | $309,258 | 12,420 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $319,519 | 12,540 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $305,448 | 12,601 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $320,221 | 12,637 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $336,479 | 12,683 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $379,634 | 13,118 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $372,106 | 13,299 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $380,785 | 13,722 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $402,973 | 13,997 | Shares | Sole | 2024-02-07 | |
| 2023-06-30 | $509,888 | 13,901 | Shares | Sole | 2023-08-22 | |
| 2023-03-31 | $591,110 | 14,488 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $746,669 | 14,572 | Shares | Sole | 2023-02-07 | |
| 2022-06-30 | $765,845 | 14,607 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $753,046 | 14,546 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $853,449 | 14,453 | Shares | Sole | 2022-03-30 | |
| 2021-09-30 | $622,096 | 14,464 | Shares | Sole | 2021-11-03 | |
| No filing history on record for this holder in this stock. | ||||||